Recognition of a ¥23.529 million valuation loss on investment securities
First written in FY2020-Q1. 3 of 17 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 35 of 80 companies on the "Worse" side.
52 other companies' latest entry also says "Other".
- FY2026Significant increase in impairment loss on investment securitiesAnnual report
「The amount, including the impairment loss on investment securities, was ¥81 million, compared with ¥2 million in the previous fiscal year.」
Extraordinary losses, including the impairment loss on investment securities, increased from ¥2 million in the previous fiscal year to ¥81 million, and the Company recognized a ¥61.841 million impairment loss on unlisted shares. - 2026-05-13AdvancedRevision of earnings forecasts
「Because the market value or substantial value of part of the investment securities held by the company had declined significantly below their acquisition cost, we will recognize an impairment loss of ¥61 million on investment securities as an extraordinary loss.」
The company specifically indicates that an impairment loss on investment securities of ¥61 million is expected to be recognized as an extraordinary loss in the fiscal year ending March 2026. - FY2026-H1Increase in impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 872 6,157」
The impairment loss on investment securities increased from ¥872 thousand in the interim period of the previous fiscal year to ¥6.157 million and was recognized as a non-operating expense. - FY2025-H1Recognition of a ¥2.995 million impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities － 2,995」
During the six-month interim period, the Company recognized a ¥2.995 million impairment loss on investment securities as an extraordinary loss. - FY2024-Q3Recognition of a ¥1.190 million impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 865 1,190」
During the nine-month period ended the third quarter, the Company recognized a ¥1.190 million impairment loss on investment securities as a non-operating expense. - FY2023-Q3RestatedAnnual report
「Impairment loss on investment securities 1,395 865」
The Company has restated the ¥865 thousand impairment loss on investment securities for the nine-month period ended the third quarter. - FY2023-Q2Recognition of a ¥865 thousand impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 1,527 865」
During the six-month period ended the second quarter, the Company recognized a ¥865 thousand impairment loss on investment securities as a non-operating expense. - FY2023-Q1Recognition of a ¥970 thousand impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities － 970」
During the three-month period ended the first quarter, the Company recognized a ¥970 thousand impairment loss on investment securities as a non-operating expense. - FY2022-Q3Recognition of a ¥1.395 million impairment loss on investment securitiesAnnual report
「Impairment loss on investment securities 2,685 1,395」
During the nine-month period ended the third quarter, the Company recognized a ¥1.395 million impairment loss on investment securities as a non-operating expense. - FY2022-Q2Recognition of a ¥1.527 million impairment loss on investment securities for the cumulative quarter-to-date periodAnnual report
「Impairment loss on investment securities 203 1,527」
During the six-month period ended the second quarter, the Company recognized a ¥1.527 million impairment loss on investment securities as a non-operating expense. - FY2021Recognition of a ¥30 million impairment loss on investment securitiesAnnual report
「During the fiscal year, the Company recognized an impairment loss of ¥30 million on securities (unlisted shares).」
The Company recognized a ¥30 million impairment loss on investment securities for unlisted shares. - FY2021-Q3Recording of a ¥2.685 million valuation loss on investment securitiesAnnual report
「Valuation loss on investment securities — ¥2.685 million」
During the cumulative consolidated period for the third quarter under review, the Company recorded a ¥2.685 million valuation loss on investment securities as a non-operating expense. - FY2021-Q2RestatedAnnual report
「Valuation loss on investment securities — ¥203,000」
Reiterates that a ¥203,000 valuation loss on investment securities was recorded as a non-operating expense during the cumulative consolidated period for the second quarter under review. - FY2021-Q1Recording of a ¥203,000 valuation loss on investment securitiesAnnual report
「Valuation loss on investment securities — ¥203,000」
During the cumulative consolidated period for the first quarter under review, the Company recorded a ¥203,000 valuation loss on investment securities as a non-operating expense. - FY2020-Q3Additional impairment loss on investment securities recognizedAnnual report
「Valuation loss on investment securities — ¥53.527 million」
During the cumulative consolidated period for the third quarter under review, the Company recorded a ¥53.527 million valuation loss on investment securities as a special loss. - FY2020-Q2RestatedAnnual report
「Valuation loss on investment securities ¥23.529 million」
Reiterates that a ¥23.529 million valuation loss on investment securities was recorded as a special loss. - FY2020-Q1First statedAnnual report
「Valuation loss on investment securities ¥23.529 million」
During the cumulative consolidated period for the first quarter under review, the Company recorded a ¥23.529 million valuation loss on investment securities.